Vaughan David Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,700	Closed	-$204K	–	153
2015 Q2	$204K	Sell	1,700 -300	-15%	-$36K	0.01%	149
2015 Q1	$209K	Buy	+2,000	New	+$209K	0.01%	149